{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:01:08Z","timestamp":1790870468826,"version":"4.1.0"},"reference-count":35,"publisher":"Society of Nuclear Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.2967\/jnumed.123.265664","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T15:10:19Z","timestamp":1689865819000},"page":"1540-1549","source":"Crossref","is-referenced-by-count":22,"title":["<sup>68<\/sup>Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study"],"prefix":"10.2967","volume":"64","author":[{"given":"David","family":"Kersting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Sandach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Sraieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Wiesweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Metzenmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaid","family":"Darwiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filiz","family":"Oezkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Servet","family":"B\u00f6l\u00fckbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stuschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Umutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Hamacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang P.","family":"Fendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Wienker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried E.E.","family":"Eberhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubertus","family":"Hautzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"2023100305301114000_64.10.1540.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0802714"},{"key":"2023100305301114000_64.10.1540.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.87"},{"key":"2023100305301114000_64.10.1540.3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl374"},{"key":"2023100305301114000_64.10.1540.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-004-1606-x"},{"key":"2023100305301114000_64.10.1540.5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.6058\/jlc.2011.10.2.69","article-title":"Somatostatin receptors in lung cancer: from function to molecular imaging and therapeutics","volume":"10","author":"Callison","year":"2011","journal-title":"J Lung Cancer."},{"key":"2023100305301114000_64.10.1540.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.0987"},{"key":"2023100305301114000_64.10.1540.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.066639"},{"key":"2023100305301114000_64.10.1540.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"2023100305301114000_64.10.1540.9","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/S1470-2045(21)00572-6","article-title":"177Lu-dotatate plus long-acting octreotide versus highdose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial","volume":"22","author":"Strosberg","year":"2021","journal-title":"Lancet Oncol."},{"key":"2023100305301114000_64.10.1540.10","doi-asserted-by":"crossref","first-page":"20033","DOI":"10.18632\/oncotarget.7706","article-title":"Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy","volume":"7","author":"Lapa","year":"2016","journal-title":"Oncotarget."},{"key":"2023100305301114000_64.10.1540.11","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/JTO.0b013e318293f051","article-title":"Brief report on the use of radiolabeled somatostatin analogs for the diagnosis and treatment of metastatic small-cell lung cancer patients","volume":"8","author":"Sollini","year":"2013","journal-title":"J Thorac Oncol."},{"key":"2023100305301114000_64.10.1540.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.186783"},{"key":"2023100305301114000_64.10.1540.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.199760"},{"key":"2023100305301114000_64.10.1540.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.235093"},{"key":"2023100305301114000_64.10.1540.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.138834"},{"key":"2023100305301114000_64.10.1540.16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1026"},{"key":"2023100305301114000_64.10.1540.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.258889"},{"key":"2023100305301114000_64.10.1540.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.261936"},{"key":"2023100305301114000_64.10.1540.19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13550-021-00765-y","article-title":"Evaluation of [68Ga]Ga-PSMA PET\/CT images acquired with a reduced scan time duration in prostate cancer patients using the digital biograph vision","volume":"11","author":"Weber","year":"2021","journal-title":"EJNMMI Res."},{"key":"2023100305301114000_64.10.1540.20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jtho.2015.10.008","article-title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth ed. of the TNM classification for lung cancer","volume":"11","author":"Nicholson","year":"2016","journal-title":"J Thorac Oncol."},{"key":"2023100305301114000_64.10.1540.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.057307"},{"key":"2023100305301114000_64.10.1540.22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13550-016-0174-y","article-title":"An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET","volume":"6","author":"Hofheinz","year":"2016","journal-title":"EJNMMI Res."},{"key":"2023100305301114000_64.10.1540.23","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1158\/1078-0432.CCR-22-1432","article-title":"Safety and efficacy of 90Y-FAPI-46 radioligand therapy in patients with advanced sarcoma and other cancer entities","volume":"28","author":"Fendler","year":"2022","journal-title":"Clin Cancer Res."},{"key":"2023100305301114000_64.10.1540.24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fmed.2019.00336","article-title":"Impact of 18F-FDG PET\/CT in staging patients with small cell lung cancer: a systematic review and meta-analysis","volume":"6","author":"Martucci","year":"2020","journal-title":"Front Med (Lausanne)."},{"key":"2023100305301114000_64.10.1540.25","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.199737"},{"key":"2023100305301114000_64.10.1540.26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13014-021-01904-4","article-title":"Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET\/CT for radiotherapy target volume definition","volume":"16","author":"Guberina","year":"2021","journal-title":"Radiat Oncol."},{"key":"2023100305301114000_64.10.1540.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91258-0"},{"key":"2023100305301114000_64.10.1540.28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2191-219X-1-19","article-title":"Binding of TS1, an anti-keratin 8 antibody, in small-cell lung cancer after 177Lu-DOTA-Tyr3-octreotate treatment: a histological study in xenografted mice","volume":"1","author":"Erlandsson","year":"2011","journal-title":"EJNMMI Res."},{"key":"2023100305301114000_64.10.1540.29","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31771"},{"key":"2023100305301114000_64.10.1540.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.12.014"},{"key":"2023100305301114000_64.10.1540.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2004.02.020"},{"key":"2023100305301114000_64.10.1540.32","doi-asserted-by":"publisher","DOI":"10.1053\/snuc.2002.31565"},{"key":"2023100305301114000_64.10.1540.33","doi-asserted-by":"crossref","unstructured":"Kim C Liu SV Subramaniam DS . Phase I study of the 177Lu-DOTA0-Tyr3-octreotate (Lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung. J Immunother Cancer. 2020;8:e000980.","DOI":"10.1136\/jitc-2020-000980"},{"key":"2023100305301114000_64.10.1540.34","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00259-021-05564-0","article-title":"Combination of terbium-161 with somatostatin receptor antagonists: a potential paradigm shift for the treatment of neuroendocrine neoplasms","volume":"49","author":"Borgna","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023100305301114000_64.10.1540.35","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.202275"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.123.265664","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T12:33:32Z","timestamp":1696336412000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.123.265664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,3]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.2967\/jnumed.123.265664"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.123.265664","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]}}}